Biometrics Built Better

Discover Veramed

Your guide to the industry and our role at 
its cutting edge.

Progress in parallel: Strategic leadership for a biotech with seven interconnected studies

Veramed provided a portfolio-wide model combining strategic oversight, technical excellence, and proactive program management, enabling the sponsor to maintain progress across multiple parallel studies while delivering critical Phase III analyses to quality and timeline expectations.   

Veramed Expands in India with New Hyderabad Office

Veramed is pleased to announce the opening of its new office in Hyderabad, marking an exciting next step

6 Best Practices for Successful DMC Implementation in Biotech Trials

For biotech sponsors, decisions made before the first meeting often have the greatest impact. Here are six best

Trust, retention and continuous improvement: Building an FSP partnership for longevity

Veramed’s long-term FSP partnership with a leading biopharmaceutical company delivers scalable biometrics and data management expertise, helping improve

Flexible teams, consistent thinking: The statistical solution biotechs need

Learn how embedded statistical support helps emerging biotechs bridge the gap between strategy and execution, providing continuous oversight,

Do you really need a DMC? Independent oversight: choose the right approach for your study

Director, Statistics, Zainab Walsh, answers some of the most common questions sponsors ask about DMCs, including when they

Maintaining study integrity in complex data-sharing environments

A large pharmaceutical sponsor needed to manage complex unblinded data access during a highly complex Phase IIb study

Stay Connected

Sign up to receive the latest insights, case studies, and Veramed news straight to your inbox.